Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
33,291,552
-
Share change
-
-1,223,513
-
Total reported value
-
$68,910,783
-
Put/Call ratio
-
66%
-
Price per share
-
$2.07
-
Number of holders
-
86
-
Value change
-
-$5,673,578
-
Number of buys
-
29
-
Number of sells
-
48
Institutional Holders of PIERIS PHARMACEUTICALS INC - COM (PIRS) as of Q3 2020
As of 30 Sep 2020,
PIERIS PHARMACEUTICALS INC - COM (PIRS) was held by
86 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,291,552 shares.
The largest 10 holders included
BVF INC/IL, Aquilo Capital Management, LLC, BlackRock Inc., Candriam Luxembourg S.C.A., RENAISSANCE TECHNOLOGIES LLC, Woodline Partners LP, Tekla Capital Management LLC, CITADEL ADVISORS LLC, VANGUARD GROUP INC, and ACADIAN ASSET MANAGEMENT LLC.
This page lists
86
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.